The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.75
Bid: 31.50
Ask: 32.00
Change: -0.25 (-0.78%)
Spread: 0.50 (1.587%)
Open: 31.75
High: 31.75
Low: 31.75
Prev. Close: 32.00
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Dealings

14 Oct 2020 13:00

RNS Number : 0924C
Duke Royalty Limited
14 October 2020
 

14 October 2020

 

Duke Royalty Limited

("Duke Royalty", "Duke" or the "Company")

Director/PDMR Dealings

 

The Company announces that certain directors [and persons discharging managerial responsibilities (PDMRs)] and their persons closely associated (PCAs) have acquired new ordinary shares in the Company ("Scrip Shares") pursuant to the recent scrip dividend, as follows.

 

Director/PDMR

No. of Scrip Shares acquired

Total resultant number of ordinary shares held in the Company

Neil Johnson 

78,926

4,047,923

Charlie Cannon Brookes

62,708

3,192,528

Arlington Asset Management*

57,447

2,764,361

Nigel Birrell

18,261

878,725

Matthew Wrigley

583

28,093

Justin Cochrane

17,623

935,528

 

*Arlington Group Asset Management Limited is a person closely associated with Charlie Cannon Brookes

 

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Neil Johnson

2

 

Reason for the notification

 

a)

 

Position/status

Chief Executive Officer

b)

 

Initial notification /Amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Duke Royalty Limited

b)

 

LEI

213800GUTKPSJ39SER44

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of nil par value

 

ISIN: GG00BYZSSY63

 

 

 

b)

 

Nature of the transaction

Acquisition of shares pursuant to scrip dividend

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

 

Scrip reference price of 23.56p per share

 

 

78,926

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

N/A

 

 

 

e)

 

Date of the transaction

 

12 October 2020

f)

 

Place of the transaction

 

London Stock Exchange

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Charlie Cannon Brookes

2

 

Reason for the notification

 

a)

 

Position/status

Executive Director

b)

 

Initial notification /Amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Duke Royalty Limited

b)

 

LEI

213800GUTKPSJ39SER44

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of nil par value

 

ISIN: GG00BYZSSY63

 

 

 

b)

 

Nature of the transaction

Acquisition of shares pursuant to scrip dividend

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

 

Scrip reference price of 23.56p per share

 

 

62,708

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

N/A

 

 

 

e)

 

Date of the transaction

 

12 October 2020

f)

 

Place of the transaction

 

London Stock Exchange

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Arlington Group Asset Management Limited

2

 

Reason for the notification

 

a)

 

Position/status

Person closely associated with Charlie Cannon Brookes, Executive Director of Duke Royalty Limited

 

b)

 

Initial notification /Amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Duke Royalty Limited

b)

 

LEI

213800GUTKPSJ39SER44

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of nil par value

 

ISIN: GG00BYZSSY63

 

 

 

b)

 

Nature of the transaction

Acquisition of shares pursuant to scrip dividend

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

 

Scrip reference price of 23.56p per share

 

 

57,447

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

N/A

 

 

 

e)

 

Date of the transaction

 

12 October 2020

f)

 

Place of the transaction

 

London Stock Exchange

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Nigel Birrell

2

 

Reason for the notification

 

a)

 

Position/status

Chairman

 

b)

 

Initial notification /Amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Duke Royalty Limited

b)

 

LEI

213800GUTKPSJ39SER44

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of nil par value

 

ISIN: GG00BYZSSY63

 

 

 

b)

 

Nature of the transaction

Acquisition of shares pursuant to scrip dividend

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

 

Scrip reference price of 23.56p per share

 

 

18,261

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

N/A

 

 

 

e)

 

Date of the transaction

 

12 October 2020

f)

 

Place of the transaction

 

London Stock Exchange

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Matthew Wrigley

2

 

Reason for the notification

 

a)

 

Position/status

Director

 

b)

 

Initial notification /Amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Duke Royalty Limited

b)

 

LEI

213800GUTKPSJ39SER44

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of nil par value

 

ISIN: GG00BYZSSY63

 

 

 

b)

 

Nature of the transaction

Acquisition of shares pursuant to scrip dividend

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

 

Scrip reference price of 23.56p per share

 

 

583

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

N/A

 

 

 

e)

 

Date of the transaction

 

12 October 2020

f)

 

Place of the transaction

 

London Stock Exchange

 

 

 

 

***ENDS***

 

For further information, please contact www.dukeroyalty.com, or contact:

 

Duke Royalty Limited

Neil Johnson / Charlie Cannon Brookes / Hugo Evans

 

+44 (0) 1481 741 240

Cenkos Securities plc 

(Nominated Adviser and Broker)

 

Stephen Keys / Callum Davidson / Julian Morse / Michael Johnson

 

+44 (0) 207 397 8900

Newgate Communications (PR)

Elisabeth Cowell/ Ian Silvera/ Megan Kovach

+ +44 (0) 20 3757 6880 dukeroyalty@newgatecomms.com

 

 

About Duke Royalty

 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKKQBPDBDDFKD
Date   Source Headline
3rd May 20247:00 amRNSFollow-On Investment into Existing Capital Partner
29th Apr 20242:45 pmEQSHardman & Co Research Initiation of Coverage on Duke Capital (DUKE): Meeting customer needs, giving investors returns
3rd Apr 20247:00 amRNSFollow-On Investment into Existing Capital Partner
2nd Apr 20247:00 amRNSNew Capital Partner - Integrum Care
28th Mar 20247:00 amRNSTrading and Operational Update
21st Mar 20247:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20247:00 amRNSSuccessful Exit of Investment in Fabrikat
6th Mar 20247:00 amRNSSuccessful Exit of Investment
4th Mar 20247:00 amRNSIncreased Equity Stake in United Glass Group
21st Feb 202411:57 amRNSName Change Effective
20th Feb 202412:08 pmRNSResult of General Meeting & Change of Name
5th Feb 20247:00 amRNSProposed Change of Name, Website and Messaging
29th Dec 20237:00 amRNSTrading Update and Follow-on Investment
19th Dec 20237:00 amRNSInterim Dividend and Dividend Declaration
29th Nov 20237:00 amRNSUpdate re. Change of Name of Nominated Adviser
22nd Nov 20237:00 amRNSFinancial Year 2024 Interim Results
21st Sep 20237:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20237:00 amRNSTrading Update
2nd Aug 20234:51 pmRNSResult of Annual General Meeting
31st Jul 20237:00 amRNSNew Royalty Agreement
28th Jul 20237:00 amRNSDirector/PDMR Dealings
20th Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
4th Jul 20237:00 amRNSFinal Results for the year ended 31 March 2023
3rd Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
26th Jun 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
15th Jun 20237:00 amRNSInterim Dividend and Dividend Declaration
9th Jun 20237:00 amRNSNotice of Results
1st Jun 20237:00 amRNSTrading Update
25th May 20237:00 amRNSDirectors' Dealings
24th May 20237:00 amRNSSuccessful Exit of Investment in Royalty Partner
22nd Mar 20237:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20237:00 amRNSNew Royalty Agreement
3rd Mar 20237:00 amRNSTrading Update
21st Feb 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
16th Jan 20237:00 amRNSClosing of New Credit Facility
15th Dec 20223:35 pmRNSInterim Dividend and Dividend Declaration
13th Dec 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
12th Dec 20227:00 amRNSRefinance and Upsize of Credit Facility
1st Dec 20227:01 amRNSTrading Update
1st Dec 20227:00 amRNS2023 Interim Results
29th Nov 202212:38 pmRNSResult of Annual General Meeting
25th Nov 20227:00 amRNSNew Royalty Agreement
14th Nov 20227:00 amRNSNotice of AGM and Notice of Interim Results
14th Oct 20227:00 amRNSPSAs, Issue of Equity & Director/PDMR Dealings
22nd Sep 20227:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20229:09 amRNSPublication of Annual Report & Accounts
9th Sep 20227:00 amRNSPostponement of Presentation
8th Sep 20227:00 amRNSFinal Results for the year ended 31 March 2022
31st Aug 20225:04 pmRNSHolding(s) in Company
30th Aug 20223:07 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.